Medical Nutrition Therapy (MNT) Business & Management Outlook

Latest Updates of Companies in the Medical Nutrition Therapy (MNT) Market

Recent Developments in the Medical Nutrition Therapy (MNT) Market

• In February 2026, Senators Collins and Peters introduced a bipartisan bill to expand medical nutrition therapy access. This therapy offers treatment for chronic conditions such as obesity and diabetes.
• In December 2025, CMS announced the Long-term Enhanced ACO Design (LEAD) Model, a novel voluntary accountable care organization (ACO) initiative from the CMS Innovation Center.

Supply Chain Analysis

R&D:

• R&D processes in medical nutrition therapy include nutrition assessment, nutrition diagnosis, nutrition intervention, monitoring, and evaluation
• Key Players: Abbott Laboratories and Nestlé Health Science

Manufacturing Processes:

• Manufacturing processes that incorporate medical nutrition therapy (MNT) span from the industrial production of clinical nutrition products to the clinical, procedural steps used by dietitians to deliver personalized care.
• Key Players: Fresenius Kabi and Danone Nutricia. 

Patient Services:

• Patient Services that include medical nutrition therapy (MNT) are evidence-based, personalized treatments designed to manage or treat medical conditions through nutritional changes, conducted by Registered Dietitian Nutritionists (RDNs).
• Key Players: Baxter International Inc. and Ajinomoto Co., Inc.

Market Growth

The global medical nutrition therapy (MNT) market size was estimated at USD 28.64 billion in 2025 and is predicted to increase from USD 30.91 billion in 2026 to approximately USD 61.38 billion by 2035, expanding at a CAGR of 7.92% from 2026 to 2035.